Comment from American College of Family Medicine

Summary: The American College of Family Medicine opposes the citizen petition to remove mifepristone safeguards, arguing that current safety data is incomplete and potentially underreports serious adverse events. They advocate for maintaining and improving post-market surveillance and REMS requirements to ensure patient safety and provide clinicians with reliable data.